KU-32, a Novel Drug for Diabetic Neuropathy, Is Safe for Human Islets and Improves In Vitro Insulin Secretion and Viability
Figure 6
mice had islets that were categorized into three types. (a) Immunofluorescence (left) and immunohistochemistry (right) illustrate the 3 types of islets that were identified in the mice. Upper panels show intact islets, middle panels include disrupted islets, and lower panels show scattered islet cells. (b) There was no statistical difference in the distribution of the islet categories between the vehicle- and KU-32-treated mice pancreata (–16 sections from each of 3 mice/group).
